NextGen Jane provides a patented at‑home menstrual blood collection kit that users mail to a central lab for high‑throughput DNA/RNA sequencing. The resulting “menstrualome” profiles are linked with longitudinal health surveys and stored in a HIPAA‑compliant cloud, where anonymized data are available via API for researchers studying gynecological conditions. Participants receive periodic personal insights and can enroll in related clinical studies.
Funding
Funding not disclosed
Founders
Product
Problem
Women lack accessible, non‑invasive methods to obtain longitudinal molecular data from the uterus, limiting early detection and precise treatment of gynecological conditions such as endometriosis, fibroids, and pregnancy complications.
Solution
NextGen Jane enables individuals to collect menstrual blood at home using a patented, organic‑cotton tampon kit that is mailed to a central laboratory for genomic analysis. Each participant also completes a detailed health and menstrual history survey, creating a paired dataset of molecular and phenotypic information. The company processes the samples with high‑throughput sequencing to generate a “menstrualome” profile, which is anonymized and stored in a secure cloud repository. Researchers can access aggregated data to identify biomarkers, develop diagnostic algorithms, and inform more targeted therapies. Participants receive periodic insights about their own data trends and can opt into specific clinical studies focused on reproductive health. The platform adheres to strict privacy standards, ensuring data are de‑identified and not shared with advertisers or insurers.
Target Audience
The primary users are menstruating individuals who join the NextGen Jane community to contribute samples and receive health insights, while the secondary audience includes biomedical researchers and healthcare organizations developing diagnostics for gynecological diseases.
Features
- Patented at‑home collection kit containing an organic cotton tampon and pre‑paid return packaging for mail‑in sampling
- Integrated longitudinal survey capturing demographics, health history, and menstrual cycle variables
- High‑throughput DNA/RNA sequencing pipeline that produces a comprehensive menstrualome profile
- Cloud‑based data integration layer linking genomic results with survey responses for cohort‑level analysis
- HIPAA‑compliant, end‑to‑end encrypted storage with full de‑identification of participant data
- API access for academic and industry researchers to query aggregated datasets for biomarker discovery
- Ongoing clinical study enrollment platform for conditions such as endometriosis, adenomyosis, fibroids, and pregnancy‑related risks
- Participant dashboard delivering personalized data summaries and study update notifications